Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine Deal [Investor's Business Daily]
ALDER BIOPHARMACEUTICALS INC (ALDR)
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.alderbio.com/node/5806
Company Research
Source: Investors Business Daily
Related news 1:14 PM ET The best pharmaceutical stocks to buy have commonalities: Strong Composite Ratings and Relative Strength Ratings. CRISPR Biotech Inks Deal To Use Stem Cells In Gene-Editing Medicine Alder Biopharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold Novartis Snags A $1.6 Billion Buy That Could Rival These Biotechs Alder Biopharmaceuticals Sees IBD RS Rating Rise To 75 The Hits Just Keep Coming For Biogen As Rival Gains MS Drug Approval Biogen Skids On Alzheimer's Flop — And Unveils Yet Another Study This Pharma Giant Slipped After FDA Rejected Its Diabetes Treatment Alder Biopharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating Novartis ( NVS ) sued its partner Amgen ( AMGN ) on Thursday, accusing the biotech of trying to renege on their agreement to sell migraine treatment Aimovig. The Swiss pharmaceutical company filed a lawsuit in a Manhattan federal court, Reuters reported. Novartis acc
Show less
Read more
Impact Snapshot
Event Time:
ALDR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALDR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALDR alerts
High impacting ALDER BIOPHARMACEUTICALS INC news events
Weekly update
A roundup of the hottest topics